A Panel of Trypanosoma brucei Strains Tagged with Blue and Red-Shifted Luciferases for Bioluminescent Imaging in Murine Infection Models

PLoS Neglected Tropical Diseases

Volumn 8, Issue 8, 2014, Pages

  Van Reet, Nick ^a   Van de Vyver, Hélène ^b   Pyana, Patient Pati ^a,c   Van der Linden, Anne Marie ^d   Büscher, Philippe ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c Institut National de Recherche Bio Medicale   (Congo)

^d UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; CELL COUNTING; CENTRAL NERVOUS SYSTEM INFECTION; DRUG SENSITIVITY; FEMALE; GENE OVEREXPRESSION; LUCIFERASE ASSAY; MOUSE; NONHUMAN; PARASITE CULTIVATION; PARASITE VIABILITY; PHASE CONTRAST MICROSCOPY; PHOTINUS PYRALIS; RED LIGHT; SENSITIVITY ANALYSIS; TRYPANOSOMA BRUCEI; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMA BRUCEI GAMBIENSE; ANIMAL; BRAIN; DISEASE MODEL; GENETICS; ISOLATION AND PURIFICATION; LUMINESCENCE; PARASITOLOGY; TRYPANOSOMIASIS, AFRICAN;

LUCIFERASE;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; FEMALE; LUCIFERASES; LUMINESCENT MEASUREMENTS; MICE; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMIASIS, AFRICAN;

EID: 84920510257     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003054     Document Type: Article

References (78)

1. World Health Organization (2013) Control and surveillance of human African trypanosomiasis. 984 http://apps.who.int/iris/bitstream/10665/95732/1/9789241209847_eng.pdf.
2. Xong HV, Vanhamme L, Chamekh M, Chimfwembe CE, Van Den Abbeele J, et al. (1998) A VSG expression site-associated gene confers resistance to human serum in Trypanosoma rhodesiense. Cell 95: 839–846.
3. Checchi F, Filipe JAN, Haydon DT, Chandramohan D, Chappuis F, (2008) Estimates of the duration of the early and late stage of gambiense sleeping sickness. BMC Infect Dis 8 doi:10.1186/1471-2334-8-16
4. Bacchi CJ, (2009) Chemotherapy of human African trypanosomiasis. Interdiscip Perspect Infect Dis 2009: 195040.
5. Giroud C, Ottones F, Coustou V, Dacheux D, Biteau N, et al. (2009) Murine models for Trypanosoma brucei gambiense disease progression-from silent to chronic infections and early brain tropism. PLoS Negl Trop Dis 3: e509.
6. Maina NW, Oberle M, Otieno C, Kunz C, Maeser P, et al. (2007) Isolation and propagation of Trypanosoma brucei gambiense from sleeping sickness patients in south Sudan. Trans R Soc Trop Med Hyg 101: 540–546.
7. Pyana PP, Ngay Lukusa I, Mumba Ngoyi D, Van Reet N, Kaiser M, et al. (2011) Isolation of Trypanosoma brucei gambiense from cured and relapsed sleeping sickness patients and adaptation to laboratory mice. PLoS Negl Trop Dis 5: e1025.
8. Kibona SN, Matemba L, Kaboya JS, Lubega GW, (2006) Drug-resistance of Trypanosoma b. rhodesiense isolates from Tanzania. Trop Med Int Health 11: 144–155.
9. World Health Organization (1986) Epidemiology and control of African trypanosomiasis. WHO Technical Report Series No 739.
10. Molyneux DH, (1973) Isolation of Trypanosoma (Trypanozoon) brucei gambiense in rabbits by the intratesticular inoculation technique. Ann Trop Med Parasitol 67: 391–397.
11. Wéry M, Weyn J, Mpela NN, Colaert J, (1977) Isolement de souches de T.gambiense au Zaïre et leur adaptation aux animaux de laboratoire. Ann Soc Belg Méd Trop 57: 425–437.
12. Büscher P, Kahremere Bin Shamamba S, Mumba D, Pyana P, Baelmans R, et al. (2005) Susceptibility of Grammomys surdaster thicket rats for Trypanosoma brucei gambiense infection. Trop Med Int Health 10: 850–855.
13. Babiker EA, Le Ray D, (1981) Adaptation of low virulence stocks of Trypanosoma brucei gambiense to rat and mouse. Ann Soc Belg Méd Trop 61: 15–29.
14. Inoue N, Narumi D, Mbati PA, Hirumi K, Situakibanza NT, et al. (1998) Susceptibility of severe combined immuno-deficient (SCID) mice to Trypanosoma brucei gambiense and T. b. rhodesiense. Trop Med Int Health 3: 408–412.
15. Zweygarth E, Kaminsky R, (1990) Direct in vitro isolation of Trypanosoma brucei brucei and T. b. evansi from disease hosts with low parasitaemia. Trop Med Parasitol 41: 56–58.
16. Masocha W, Kristensson K, (2012) Passage of parasites across the blood-brain barrier. Virulence 3: 202–212.
17. Jennings FW, Whitelaw DD, Holmes PH, Chizyuka HGB, Urquhart GM, (1979) The brain as a source of relapsing Trypanosoma brucei infection in mice after chemotherapy. J Parasitol 9: 381–384.
18. Poltera AA, (1985) Pathology of human African trypanosomiasis with reference to experimental African trypanosomiasis and infections of the central nervous system. Br Med Bull 41: 169–174.
19. Jennings FW, Hunter CA, Kennedy PGE, Murray M, (1993) Chemotherapy of Trypanosoma brucei infection of the central nervous system: the use of a rapid chemotherapeutic regimen and the development of post-treatment encephalopathies. Trans R Soc Trop Med Hyg 87: 224–226.
20. Beckers A, Wéry M, Van Marck E, Gigase P, (1981) Experimental infections of laboratory rodents with recently isolated stocks of Trypanosoma brucei gambiense. 1. Parasitological investigations. Z Parasitenkd 64: 285–296.
21. Van Marck EA, Gigase PL, Beckers A, Wéry M, (1981) Experimental infections of laboratory rodents with recently isolated stocks of Trypanosoma brucei gambiense. 2. Histopathological investigations. Z Parasitenkd 64: 187–193.
22. Mulumba PM, Wéry M, (1983) Experimental infection with two stocks of Trypanosoma brucei gambiense. Contrib Microbiol Immunol 7: 120–129.
23. Poltera AA, (1983) Chemotherapy, relapses and CNS in experimental African trypanosomiasis. Contrib Microbiol Immunol 7: 155–164.
24. Holzmüller P, Biron DG, Courtois P, Koffi M, Bras-Goncalves R, et al. (2008) Virulence and pathogenicity patterns of Trypanosoma brucei gambiense field isolates in experimentally infected mouse: differences in host immune response modulation by secretome and proteomics. Microbes Infect 10: 79–86.
25. Smith DH, Bailey JW, (1997) Human African trypanosomiasis in south-eastern Uganda: clinical diversity and isoenzyme profiles. Ann Trop Med Parasitol 91: 851–856.
26. Gibson WC, (1986) Will the real Trypanosoma b. gambiense please stand up? Parasitol Today 2: 255–257.
27. Goodhead I, Capewell P, Bailey W, Beament T, Chance M, et al. (2013) Whole-genome sequencing of Trypanosoma brucei reveals introgression between subspecies that is associated with virulence. mBio 4: 1–8.
28. Andreu N, Zelmer A, Wiles S, (2011) Noninvasive biophotonic imaging for studies of infectious disease. FEMS Microbiol Rev 35: 360–394.
29. Myburgh E, Coles JA, Ritchie R, Kennedy PG, McLatchie AP, et al. (2013) In vivo imaging of trypanosome-brain interactions and development of a rapid screening test for drugs against CNS stage trypanosomiasis. PLoS Negl Trop Dis 7: e2384.
30. Claes F, Vodnala SK, Van Reet N, Boucher N, Lunden-Miguel H, et al. (2009) Bioluminescent imaging of Trypanosoma brucei shows preferential testis dissemination which may hamper drug efficacy in sleeping sickness patients. PLoS Negl Trop Dis 3: e486.
31. Bhaumik S, Lewis XZ, Gambhir SS, (2004) Optical imaging of Renilla luciferase, synthetic Renilla luciferase, and firefly luciferase reporter gene expression in living mice. J Biomed Opt 9: 578–586.
32. Wood KV, Lam YA, McElroy WD, (1989) Introduction to beetle luciferases and their applications. J Biolum Chemilum 4: 289–301.
33. Hastings JW, (1996) Chemistries and colors of bioluminescent reactions: a review. Gene 173: 5–11.
34. Sommer JM, Cheng QL, Keller GA, Wang CC, (1992) In vivo import of firefly luciferase into the glycosomes of Trypanosoma brucei and mutational analysis of the C-terminal targeting signal. Mol Biol Cell 3: 749–759.
35. D'Archivio S, Cosson A, Medina M, Lang T, Minoprio P, et al. (2013) Non-invasive in vivo study of the Trypanosoma vivax infectious process consolidates the brain commitment in late infections. PLoS Negl Trop Dis 7: e1976.
36. Doyle TC, Burns SM, Contag CH, (2004) In vivo bioluminescence imaging for integrated studies of infection. Cell Microbiol 6: 303–317.
37. Branchini BR, Ablamsky DM, Davis AL, Southworth TL, Butler B, et al. (2010) Red-emitting luciferases for bioluminescence reporter and imaging applications. Anal Biochem 396: 290–297.
38. Miloud T, Henrich C, Hammerling GJ, (2007) Quantitative comparison of click beetle and firefly luciferases for in vivo bioluminescence imaging. J Biomed Opt 12: 054018.
39. Liang Y, Walczak P, Bulte JW, (2012) Comparison of red-shifted firefly luciferase Ppy RE9 and conventional Luc2 as bioluminescence imaging reporter genes for in vivo imaging of stem cells. J Biomed Opt 17: 016004.
40. McLatchie AP, Burrell-Saward H, Myburgh E, Lewis MD, Ward TH, et al. (2013) Highly sensitive in vivo imaging of Trypanosoma brucei expressing “red-shifted” luciferase. PLoS Negl Trop Dis 7: e2571.
41. Schultzberg M, Ambatsis M, Samuelsson E-B, Kristensson K, Van Meirvenne N, (1988) Spread of Trypanosoma brucei to the nervous system: early attack on circumventricular organs and sensory ganglia. J Neurosci Res 21: 56–61.
42. Keita M, Bouteille B, Enanga B, Vallat J-M, Dumas M, (1997) Trypanosoma brucei brucei: a long-term model of human African trypanosomiasis in mice, meningo-encephalitis, astrocytosis, and neurological disorders. Exp Parasitol 85: 183–192.
43. Rickman LR, (1974) Investigations into an outbreak of human trypanosomiasis in the lower Luangwa Valley, Eastern Province, Zambia. East Afr Med J 51: 467–487.
44. MacLean L, Chisi JE, Odiit M, Gibson WC, Ferris V, et al. (2004) Severity of human African trypanosomiasis in East-Africa is associated with geographic location, parasite genotype and host inflammatory cytokines response profile. Infect Immun 72: 7040–7044.
45. Magnus E, Vervoort T, Van Meirvenne N, (1978) A card-agglutination test with stained trypanosomes (C.A.T.T.) for the serological diagnosis of T.b.gambiense trypanosomiasis. Ann Soc Belg Méd Trop 58: 169–176.
46. Büscher P, Gilleman Q, Lejon V, (2013) Novel rapid diagnostic test for sleeping sickness. N Engl J Med 368: 1069–1070.
47. Mumba Ngoyi D, Lejon V, Pyana P, Boelaert M, Ilunga M, et al. (2010) How to shorten patient follow-up after treatment for Trypanosoma brucei gambiense sleeping sickness? J Infect Dis 201: 453–463.
48. Graf FE, Ludin P, Wenzler T, Kaiser M, Brun R, et al. (2013) Aquaporin 2 mutations in Trypanosoma brucei gambiense field isolates concur with decreased susceptibility to pentamidine and melarsoprol. PLoS Negl Trop Dis 7: e2475.
49. Hirumi H, Hirumi K, (1989) Continuous cultivation of Trypanosoma brucei blood stream forms in a medium containing a low concentration of serum protein without feeder cell layers. J Parasitol 75: 985–989.
50. McCulloch R, Vassella E, Burton P, Boshart M, Barry JD, (2004) Transformation of monomorphic and pleomorphic Trypanosoma brucei. Methods Mol Biol 262: 53–86.
51. Van Reet N, Pyana PP, Deborggraeve S, Büscher P, Claes F, (2011) Trypanosoma brucei gambiense: HMI-9 medium containing methylcellulose and human serum supports the continuous axenic in vitro propagation of the bloodstream form. Exp Parasitol 128: 285–290.
52. Van Reet N, Pyana PP, Rogé S, Claes F, Büscher P, (2013) Luminescent multiplex viability assay for Trypanosoma brucei gambiense. Parasit Vectors 6: 207.
53. Gillingwater K, Büscher P, Brun R, (2007) Establishment of a panel of reference Trypanosoma evansi and Trypanosoma equiperdum strains for drug screening. Vet Parasitol 148: 114–121.
54. Räz B, Iten M, Grether-Bühler Y, Kaminsky R, Brun R, (1997) The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. gambiense) in vitro. Acta Trop 68: 139–147.
55. Heikkilä JE, Vaha-Koskela MJ, Ruotsalainen JJ, Martikainen MW, Stanford MM, et al. (2010) Intravenously administered alphavirus vector VA7 eradicates orthotopic human glioma xenografts in nude mice. PLoS ONE 5: e8603.
56. Herbert WJ, Lumsden WHR, (1976) Trypanosoma brucei: A rapid “matching” method for estimating the host's parasitemia. Exp Parasitol 40: 427–431.
57. Pichler A, Prior JL, Piwnica-Worms D, (2004) Imaging reversal of multidrug resistance in living mice with bioluminescence: MDR1 P-glycoprotein transports coelenterazine. Proc Natl Acad Sci USA 101: 1702–1707.
58. Mulenga C, Mhlanga JD, Kristensson K, Robertson BD, (2001) Trypanosoma brucei brucei crosses the blood-brain barrier while tight junction proteins are preserved in a rat chronic disease model. Neuropathol Appl Neurobiol 27: 77–85.
59. Otto-Duessel M, Khankaldyyan V, Gonzalez-Gomez I, Jensen MC, Laug WE, et al. (2006) In vivo testing of Renilla luciferase substrate analogs in an orthotopic murine model of human glioblastoma. Mol Imaging 5: 57–64.
60. Aswendt M, Adamczak J, Couillard-Despres S, Hoehn M, (2013) Boosting bioluminescence neuroimaging: an optimized protocol for brain studies. PLoS ONE 8: e55662.
61. Loening AM, Dragulescu-Andrasi A, Gambhir SS, (2010) A red-shifted Renilla luciferase for transient reporter-gene expression. Nature Meth 7: 5–6.
62. Gil JS, Machado HB, Herschman HR, (2012) A method to rapidly and accurately compare the relative efficacies of non-invasive imaging reporter genes in a mouse model and its application to luciferase reporters. Mol Imag Biol 14: 462–471.
63. Jackson AP, Vaughan S, Gull K, (2006) Evolution of tubulin gene arrays in Trypanosomatid parasites: genomic restructuring in Leishmania. BMC Genomics 7: 261.
64. Kanmogne GD, Bailey M, Gibson WC, (1997) Wide variation in DNA content among isolates of Trypanosoma brucei ssp. Acta Trop 63: 75–87.
65. Close DM, Xu T, Sayler GS, Ripp S, (2011) In vivo bioluminescent imaging (BLI): noninvasive visualization and interrogation of biological processes in living animals. Sensors 11: 180–206.
66. Morrison LJ, Tait A, McLellan S, Sweeney L, Turner CM, et al. (2009) A major genetic locus in Trypanosoma brucei is a determinant of host pathology. PLoS Negl Trop Dis 3: e557.
67. Mekata H, Konnai S, Mingala CN, Abes NS, Gutierrez CA, et al. (2013) Isolation, cloning, and pathologic analysis of Trypanosoma evansi field isolates. Parasitol Res 112: 1513–1521.
68. Darsaud A, Bourdon L, Chevrier C, Keita M, Bouteille B, et al. (2003) Clinical follow-up in the rat experimental model of African trypanosomiasis. Experimental Biology and Medicine 228: 1355–1362.
69. Chevrier C, Canini F, Darsaud A, Cespuglio R, Buguet A, et al. (2005) Clinical assessment of the entry into neurological state in rat experimental African trypanosomiasis. Acta Trop 95: 33–39.
70. Song HT, Jordan EK, Lewis BK, Liu W, Ganjei J, et al. (2009) Rat model of metastatic breast cancer monitored by MRI at 3 tesla and bioluminescence imaging with histological correlation. J Travel Med 7: 88.
71. Herwaldt BL, (2001) Laboratory-acquired parasitic infections from accidental exposures. Clin Microbiol Rev 14: 659–688.
72. Van Marck EAE, Le Ray D, Beckers A, Jacob W, Wéry M, et al. (1981) Light and electron microscope studies on extravascular Trypanosoma brucei gambiense in the brain of chronically infected rodents. Ann Soc Belg Méd Trop 61: 57–78.
73. Chirimwami B, Van Marck EA, Brucher JM, Wery M, Gigase PL, (1988) Progression of central nervous system lesions in the rat infected with Trypanosoma brucei gambiense. A light microscopic study. Ann Soc Belg Méd Trop 68: 205–218.
74. Poltera AA, Hochmann A, Rudin W, Lambert PH, (1980) Trypanosoma brucei brucei: a model for cerebral trypanosomiasis in mice - an immunological, histological and electronmicroscopic study. Clin Exp Immunol 40: 496–507.
75. Urech K, Neumayr A, Blum J, (2011) Sleeping sickness in travelers - do they really sleep? PLoS Negl Trop Dis 5: e1358.
76. Simarro PP, Franco JR, Cecchi G, Paone M, Diarra A, et al. (2012) Human African trypanosomiasis in non-endemic countries (2000–2010). J Travel Med 19: 135.
77. Le Ray D, Barry JD, Easton C, Vickerman K, (1977) First tsetse fly transmission of the “AnTat” serodeme of Trypanosoma brucei. Ann Soc Belg Méd Trop 57: 369–381.
78. Van Meirvenne N, Magnus E, Vervoort T, (1977) Comparisons of variable antigenic types produced by trypanosome strains of the subgenus Trypanozoon. Ann Soc Belg Méd Trop 57: 409–423.